Patent details

EP2050464 Title: Streptococcus pneumoniae proteins and immunogenic fragments for vaccines

Basic Information

Publication number:
EP2050464
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP090012063
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
French Title of Invention:
Protéines de streptococcus pneumoniae et fragments immunogènes pour vaccins
German Title of Invention:
Streptocuccus Pneumoniae Proteine und immunogene Fragmente für Impfstoffe
SPC Number:

Dates

Filing date:
21/12/1999
Grant date:
07/08/2019
EP Publication Date:
22/04/2009
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/12/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
MEDIMMUNE, INC.
Address:
35 West Watkins Mill Road, Gaithersburg, MD 29878, United States (US)

Inventor

1

Name:
Johnson, Leslie S.
Address:
United States (US)

2

Name:
Koenig, Scott
Address:
United States (US)

3

Name:
Adamou, John E.
Address:
United States (US)

Priority

Priority Number:
113048 P
Priority Date:
21/12/1998
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/09; A61K 39/40; A61P 31/04; C07K 14/315;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)
Filing date Document type Number of pages